RxDoctor Payments Data

Benjamin Guidry, MD

Ophthalmology · Metairie, LANPI 1770807315

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $7,469 of the $8,729 with a category attached, or 85.6%. 30 manufacturers reported payments, led by Alimera Sciences, Inc. at 28.0% of the total. Among ophthalmology clinicians in LA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$8,729in general payments, 2019–2025

Across 184 payments — averaging $47.44 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Alimera Sciences, Inc.$2K
  • Regeneron Healthcare Solutions, Inc.$1K
  • Coherus Oncology, Inc.$626
  • Genentech USA, Inc.$445
  • Apellis Pharmaceuticals, Inc.$400
  • Regeneron$394
  • plus $3K from 24 others

What the payments were for

  • Speaking & faculty fees$1,20014%
  • Food & beverage$7,46986%
  • Gifts$190%
  • Entertainment$400%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$8,729 in reported general payments places this provider in the 90th percentile of 286 ophthalmology providers in Louisiana.

See all ophthalmology providers in Louisiana

Medicare billing

Part B allowed, 2024
$1,358,907
Medicare patients
527
Services billed
18,479

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Prednisolone Acetate75$3,256
Ketorolac Tromethamine50$1,245
Latanoprost96$1,013
Timolol Maleate50$563
Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat32$447
Ofloxacin26$326
Brimonidine Tartrate25$101

Paid to pharmacies, not to this prescriber.

Other ophthalmology in Metairie

See the full list for Louisiana

Where these figures come from

Is this you, or does something look wrong? →